Response to Comment on “Cutting Edge: Epigenetic Regulation ofFoxp3Defines a Stable Population of CD4+Regulatory T Cells in Tumors From Mice and Humans”

Journal of Immunology - United States
doi 10.4049/jimmunol.1500367
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Response to Comment on "Cutting Edge: Anti-Cd25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells"

Journal of Immunology
AllergyImmunology
2006English

Comment on "Cutting Edge: Depletion of Foxp3+ Cells Leads to Induction of Autoimmunity by Specific Ablation of Regulatory T Cells in Genetically Targeted Mice"

Journal of Immunology
AllergyImmunology
2010English

Response to Comment on "Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses"

Journal of Immunology
AllergyImmunology
2011English

Cutting Edge: CD8+CD122+ Regulatory T Cells Produce IL-10 to Suppress IFN- Production and Proliferation of CD8+ T Cells

Journal of Immunology
AllergyImmunology
2005English

Cutting Edge: Leptin-Induced ROR T Expression in CD4+ T Cells Promotes Th17 Responses in Systemic Lupus Erythematosus

Journal of Immunology
AllergyImmunology
2013English

Cutting Edge: Control of Mycobacterium Tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells

Journal of Immunology
AllergyImmunology
2014English

Reply to Comment on "Stability of Human Rapamycin-Expanded CD4+CD25+ T-Regulatory Cells" Haematologica 2011;96(9):1357-65

Haematologica
Hematology
2012English

Cutting Edge: Receptors for C3a and C5a Modulate Stability of Alloantigen-Reactive Induced Regulatory T Cells

Journal of Immunology
AllergyImmunology
2013English

GRAIL Is Up-Regulated in CD4+CD25+T Regulatory Cells and Is Sufficient for Conversion of T Cells to a Regulatory Phenotype

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy